Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 217.0 | 64 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 136.5 | 60 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 61.0 | 65 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 55.0 | 77 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 57.5 | 86 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 51.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 158.0 | 53 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | HGF | 117.5 | 56 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 61.0 | 55 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | HGF | 66.0 | 50 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | HGF | 59.0 | 51 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | HGF | 59.0 | 36 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 100.5 | 54 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 67.0 | 55 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 37.0 | 52 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 34.0 | 77 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 33.0 | 53 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 34.5 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 112.0 | 60 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | HGF | 95.0 | 62 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 45.0 | 65 | |
N2645 | TNF-a | 100 | ng/mL | 4 | HGF | 39.0 | 65 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | HGF | 35.5 | 48 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | HGF | 35.0 | 49 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | HGF | 215.0 | 43 |